TPH1 and neoplasm: The tumor can regulate a number of factors to suppress the melatonergic pathway in other cells, including suppressing tryptophan availability, and tryptophan uptake, as well as the conversion of tryptophan to serotonin, which requires TPH, with TPH2 requiring 14-3-3e for its stabilization.